新股定价 | 旺山旺水以接近上限定价,公开发售超购6237倍,一手中签率1.68%

老虎资讯综合
Nov 06, 2025

生物医药公司旺山旺水-B(02630)公布招股结果,香港公开发售接获6,238.42倍认购,一手(200股)中签率1.68%。国际发售录得16.87倍认购。

旺山旺水-B以接近上限每股33.37港元定价,以目标发行股数1,759.8万股计,料集资5.87亿港元。股份今日(6日)上市。

旺山旺水本次拟全球发售1,759.78万股H股,公开发售占10%。招股价介乎32-34港元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10